2,237 Shares in DocuSign, Inc. (NASDAQ:DOCU) Purchased by Verus Capital Partners LLC

Verus Capital Partners LLC bought a new position in DocuSign, Inc. (NASDAQ:DOCU) during the fourth quarter, Holdings Channel reports. The firm bought 2,237 shares of the company’s stock, valued at approximately $201,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in DOCU. Creative Planning raised its holdings in shares of DocuSign by 5.6% in the 3rd quarter. Creative Planning now owns 14,453 shares of the company’s stock worth $897,000 after acquiring an additional 766 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in DocuSign by 13.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,466 shares of the company’s stock valued at $214,000 after buying an additional 413 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in DocuSign by 77.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 14,603 shares of the company’s stock valued at $907,000 after buying an additional 6,390 shares during the last quarter. Nisa Investment Advisors LLC purchased a new stake in DocuSign in the 3rd quarter valued at about $1,503,000. Finally, abrdn plc increased its stake in DocuSign by 67.8% in the 3rd quarter. abrdn plc now owns 56,172 shares of the company’s stock valued at $3,488,000 after buying an additional 22,689 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on DOCU. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a research note on Tuesday, February 4th. Jefferies Financial Group increased their price objective on shares of DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Hsbc Global Res upgraded shares of DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. Morgan Stanley increased their price objective on shares of DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. Finally, UBS Group increased their target price on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $92.45.

Insider Buying and Selling

In related news, insider Robert Chatwani sold 14,800 shares of the firm’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $97.76, for a total value of $1,446,848.00. Following the completion of the transaction, the insider now directly owns 73,414 shares of the company’s stock, valued at approximately $7,176,952.64. This trade represents a 16.78 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Allan C. Thygesen sold 7,763 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total transaction of $625,232.02. Following the completion of the transaction, the chief executive officer now directly owns 100,062 shares of the company’s stock, valued at approximately $8,058,993.48. This trade represents a 7.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 693,773 shares of company stock valued at $66,727,926. Company insiders own 1.66% of the company’s stock.

DocuSign Trading Up 2.3 %

DOCU opened at $83.17 on Friday. The company has a 50 day moving average of $90.43 and a 200 day moving average of $77.74. The company has a market cap of $16.80 billion, a PE ratio of 17.15, a price-to-earnings-growth ratio of 6.94 and a beta of 0.89. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.